Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Subviral Agents01:29

Subviral Agents

373
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
373

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High pathogenicity avian influenza A (H5N1) viruses isolated from poultry and wild birds in Japan during the 2024-2025 season.

Microbiology spectrum·2026
Same author

Practical Real-Time Quaking-Induced Conversion for Detecting Classical Bovine Spongiform Encephalopathy and Classical and Atypical Scrapie Prions.

Pathogens (Basel, Switzerland)·2026
Same author

Pathogenic and Antigenic Analyses of H5N1 High Pathogenicity Avian Influenza Virus Isolated in the 2022/2023 Season From Poultry Farms in Izumi City, Japan.

Transboundary and emerging diseases·2025
Same author

Phylogenetic and Pathogenic Analysis of H5N1 and H5N6 High Pathogenicity Avian Influenza Virus Isolated from Poultry Farms (Layer and Broiler Chickens) in Japan in the 2023/2024 Season.

Viruses·2025
Same author

Long-term immune responses induced by low-dose infection with high pathogenicity avian influenza viruses can protect mallards from reinfection with a heterologous strain.

Archives of virology·2025
Same author

Development of an intestinal epithelial cell line and organoids derived from the same swine and characterization of their antiviral responses.

Bioscience of microbiota, food and health·2024

Related Experiment Video

Updated: Dec 17, 2025

Purification and Refolding to Amyloid Fibrils of His6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli
09:43

Purification and Refolding to Amyloid Fibrils of His6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli

Published on: December 19, 2015

14.6K

Agent-specific Shadoo responses in transmissible encephalopathies.

Kohtaro Miyazawa1, Laura Manuelidis

  • 1Yale University Medical School, 333 Cedar Street, New Haven, CT 06510, USA.

Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|January 30, 2010
PubMed
Summary

Shadoo (Sho) protein reductions in transmissible spongiform encephalopathies (TSE) are agent-specific and not essential for infection. Sho does not appear to protect against toxic prion protein effects.

More Related Videos

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
11:41

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Published on: March 10, 2015

8.1K
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
08:38

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

20.8K

Related Experiment Videos

Last Updated: Dec 17, 2025

Purification and Refolding to Amyloid Fibrils of His6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli
09:43

Purification and Refolding to Amyloid Fibrils of His6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli

Published on: December 19, 2015

14.6K
Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay
11:41

Assessing Transmissible Spongiform Encephalopathy Species Barriers with an In Vitro Prion Protein Conversion Assay

Published on: March 10, 2015

8.1K
Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge
08:38

Overcoming Unresponsiveness in Experimental Autoimmune Encephalomyelitis EAE Resistant Mouse Strains by Adoptive Transfer and Antigenic Challenge

Published on: April 9, 2012

20.8K

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
  • Host prion protein (PrP) is crucial for TSE pathogenesis.
  • Shadoo (Sho) protein is structurally similar to PrP and its role in TSEs is unknown.

Purpose of the Study:

  • To investigate Shadoo (Sho) protein changes in response to various TSE agents.
  • To determine if Sho is required for TSE infection or protects against PrP toxicity.

Main Methods:

  • Infection of standard mice and Tga20 mice (high PrP levels) with distinct TSE agents (sporadic CJD, Asiatic CJD, kuru, vCJD, 22L scrapie).
  • Analysis of Sho and PrP levels and regional neuropathology.
  • Infection of neural GT1 cells with TSE agents.

Main Results:

  • Sho reductions were specific to the TSE agent used.
  • Sho levels did not consistently correlate with PrP misfolding.
  • Sho was not essential for TSE infection in GT1 cells, which remained healthy despite abundant abnormal PrP.

Conclusions:

  • Sho reduction is an agent-specific TSE hallmark, not a universal response.
  • Sho is not required for TSE infection and does not protect against the toxic effects of misfolded PrP.